Phase 2 N=60 Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
Metastatic Breast Cancer
Primary: Best Overall Tumor Response — 2; 27; 20; 7 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=96 A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Primary: Time to Progression (TTP) — 263; 147 days — p=0.016
Phase 2 N=50 Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis
Osteoarthritis
Primary: Change From Baseline in the Ankle Osteoarthritis Scale (AOS) Score at 6 Months — 2.3 score on a scale — p=<0.05
Phase 2 N=45 Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder
Primary: Number of Participants With Adverse Events Leading to Discontinuation — 1; 1; 1 participants
Phase 2 N=82 Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486
Prostate Cancer
Primary: Time to Meet Insufficient Testosterone Response — 14; 77; 98; 28 days — p=<0.001
Phase 2 N=24 The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)
Essential Thrombocythaemia
Primary: Maximum Plasma Concentration (Cmax) of Agrylin — 2.66; 3.63 ng/ml — p=0.092
Phase 2 N=488 Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
Malignant Melanoma
Primary: Overall Tumor Response — 7; 10; 6; 12 participants
Phase 2 N=217 Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
Alzheimer Disease
Primary: Change From Baseline in Alzheimer's Disease Assessment Scale Cognitive Subpart (Extended Version) (ADAS-COG+) at Week 28 — -2.348; -1.711; -1.246 points on a scale…
Phase 2 N=37 Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Breast Cancer · Breast Neoplasms, Male · Carcinoma, Ductal
Primary: Overall Tumor Response — 1; 8; 14; 9 participants
Phase 2 N=48 Safety and Efficacy Study on the Implantation of the Tension-Free Vaginal Tape (TVT-Secur) Under Local Anesthesia
Urinary Stress Incontinence
Primary: Local Anesthesia Satisfaction — 43; 3 participants
Phase 2 N=173 Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine
Meningitis · Meningococcemia · Neisseria Meningitidis
Primary: Geometric Mean Titers (GMT) of Serum Bactericidal Activity for Each Vaccine Serogroups Before and Post-vaccination. — 316.1; 126.5; 11411.9; 6720.1 Titers
Phase 2 N=68 Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
Metastatic Breast Cancer
Primary: Tumor Response — 0; 1; 0; 4 participants
Phase 2 N=257 Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens
Breast Cancer
Primary: Number of Participants With a Pathological Complete Response — 21; 24; 99; 89 participants
Phase 2 N=73 Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Breast Cancer · Breast Neoplasms
Primary: Overall Tumor Response — 2; 0; 8; 5 participants
Phase 2 N=33 Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
Growth Hormone Therapy · Infant, Very Low Birth Weight
Primary: Change in Height Standard Deviation Score (SDS) After 1 Year — 1.099; 0.108 centimeters — p=<0.001